¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chronic hypocomplementemic glomerulonephritis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® poststreptococcal glomerulonephritis ÇÑ±Û »ç½½¾Ë±Õ°¨¿°ÈÄÅ丮ÄáÆÏ¿°, ¿¬¼â±¸±Õ°¨¿°ÈĻ籸ü½Å¿°
¼³¸í   
  Á¡Â÷ °¨¼ÒÃß¼¼À̱â´Â Çϳª ¾î¸°ÀÌ ÄáÆÏº´À¸·Î ¾ÆÁÖ ÈçÇÏ´Ù. »ç½½¾Ë±Õ °¨¿°, Æ¯È÷ »ó±âµµ³ª ÇǺΠ°¨¿° ÈÄ 1ÁÖ ³»Áö 2ÁÖ À̳»¿¡ ±Þ¼ºÄáÆÏ¿°ÁõÈıºÀÌ °©Àڱ⠹ßÇöµÇ´Â Æ¯Â¡À» º¸ÀδÙ. ¼ºÀο¡¼­µµ ¹ß»ýÇÒ ¼ö ÀÖÀ¸³ª ºñ±³Àû µå¹°°í ±× ÀÓ»ó¼Ò°ßÀÌ ´Ù¼Ò ´Ù¸¦ ¼ö ÀÖ´Ù. ¹ß»ý¸ÞÄ¿´ÏÁòÀº ¸é¿ªÀ¸·Î Çؼ®Çϰí ÀÖ´Ù.
¿µ¹® glomerulonephritis ÇÑ±Û Å丮ÄáÆÏ¿°, »ç±¸Ã¼½Å¿°
¼³¸í   
  Å丮ÄáÆÏ¿°À̶õ ÀÌ Å丮ÀÇ ¿°ÁõÀ» ÁַΠÇϴ ÄáÆÏº´À» ¸»ÇÑ´Ù. ÀÌ Å丮ÄáÆÏ¿°ÀÇ Áø´ÜÀº ÇÏÁö¸¸ Çö¹Ì°æÀû °üÂû·Î Å丮ÀÇ ¿°ÁõÀ» º¸°í Áø´ÜÇϴ °ÍÀÌ ¾Æ´Ï¶ó ÀÓ»óÁõ¼¼·Î Áø´ÜÇϴ °ÍÀ̹ǷΠ´ÙºÐÈ÷ ÀÓ»óÀûÀΠÁø´Ü¸íÀÌ´Ù. Áï ½ÉÇϰԠ¸»Çϸ頽ÇÁ¦·Î Å丮ÀÇ ¿°ÁõÀÌ ¾ø´Â °æ¿ì¿¡µµ ÀÓ»óÀû Áø´Ü ±âÁØ¿¡¸¸ ÇÕ´çÇÑ °æ¿ì¿¡´Â Å丮ÄáÆÏ¿°À¸·Î Áø´ÜÀÌ ³»·ÁÁú ¼ö°¡ ÀÖ´Ù.
  
  Å丮ÄáÆÏ¿°Àº ±Þ¼º°ú ¸¸¼ºÀÇ µÎ °¡Áö·Î ³ª´­ ¼ö°¡ ÀÖ´Ù.
  
  1.±Þ¼ºÅ丮ÄáÆÏ¿°£­°©ÀÛ½º·´°Ô ¹ß»ýÇϴ Ç÷´¢, ´Ü¹é´¢, ±×¸®°í ÄáÆÏÀÇ ±â´ÉºÎÀüÀ¸·Î ÀÎÇØ¼­ ¼öºÐÀ̳ª ÀüÇØÁúÀǠü³» ÃàÀû, ºÒ¼ø¹°ÀǠü³»ÃàÀûÀÌ Àִ º´À» ¸»ÇÑ´Ù. ÀÌ ±Þ¼º Å丮ÄáÆÏ¿°À» ÀÏÀ¸Å°´Â ¿øÀÎÀ¸·Î´Â ¿©·¯°¡Áö°¡ ÀÖÁö¸¸ ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ´ëºÎºÐ °¨¿°(»ç½½¾Ë±Õ, Æ÷µµ¾Ë±Õ, Æó·Å¾Ë±Õ, ¿©·¯ ¹ÙÀÌ·¯½º µî)ÈÄ¿¡ ÃÊ·¡µÇ´Â °¨¿°ÈÄ Å丮ÄáÆÏ¿°ÀÌ ÀÖ´Ù. ¿©·¯ °¨¿°ÀÌ ±Þ¼º Å丮ÄáÆÏ¿°À» ÀÏÀ¸Å°³ª Æ¯È÷ »ç½½¾ËÀÇ °¨¿°ÀÌ °¡Àå ÀüÇüÀûÀΠ¿¹¶ó°í ÇÒ ¼ö ÀÖ´Ù.
  
  2.¸¸¼ºÅ丮ÄáÆÏ¿°-Áö¼ÓÀûÀΠ¿ä°Ë»ç»óÀÇ ÀÌ»ó, Áܹ鴢, Ç÷´¢¿Í ½ÅÀåÀÇ ±â´ÉÀÌ ¼­¼­È÷ ¾ø¾îÁö´Â Áúȯ±ºÀÌ´Ù. ÈçÈ÷ ¸»±âÄáÆÏÀ̶ó ºÎ¸£¸ç °ÅÀÇ ¸ðµç ÄáÆÏÀÇ º´ÀÌ ÀÌ ¸¸¼º Å丮ÄáÆÏ¿°À¸·Î ÁøÇàµÈ´Ù. 
¿µ¹® chronic lymphocytic leukemia ÇÑ±Û ¸¸¼º¸²ÇÁ¼º ¹éÇ÷º´
¼³¸í   
  ¹éÇ÷º´(leukemia)¶õ ºñÁ¤»óÀûÀΠ¹éÇ÷±¸ ¼¼Æ÷ÀÇ Áõ½Ä¿¡ ÀÇÇØ ÀϾ´Â º´ÀûÀΠ»óŸ¦ ¸»Çϴµ¥, ÈçÈ÷ ¸»ÃÊÇ÷¾×¿¡ ¹ÌºÐÈ­¼¼Æ÷°¡ ³ªÅ¸³ª¸ç, Á¤»óÀûÀΠÀûÇ÷±¸¼¼Æ÷¿Í ¹éÇ÷±¸¼¼Æ÷, Ç÷¼ÒÆÇÀÇ ±Þ°ÝÇÑ °¨¼Ò¸¦ °¡Á®¿Í Á¤»óÀûÀΠ¼¼Æ÷¿¡ ÀÇÇØ ÇàÇØÁö´Â ¿©·¯ ±â´ÉÀÇ °¨¼Ò¸¦ ÁÖÁõ»óÀ¸·Î ÇÏ¿© º´¿ø¿¡ Ã£¾Æ¿À°Ô µÈ´Ù. µû¶ó¼­ ÀûÇ÷±¸¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ºóÇ÷, ¹éÇ÷±¸¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ¸¹Àº °¨¿°Áõ¼¼(ÈçÈ÷ °É¸®Áö ¾Ê´Â ¼¼±Õ¿¡ ÀÇÇÑ °¨¿°, Áö³ªÄ¡°Ô ÀæÀº °¨±â, Æó·Å µî), Ç÷¼ÒÆÇ¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ÃâÇ÷Áõ»óÀÌ ³ªÅ¸³­´Ù. ¶ÇÇÑ ÇǸ¦ »ý»êÇϴ °ñ¼ö Á¶Á÷¿¡¼­´Â ÀÌ·± ºñÁ¤»óÀûÀΠ¼¼Æ÷ÀÇ Áõ½Ä¸¸À» º¼ ¼ö ÀÖÀ¸¸ç, Á¤»óÀûÀΠ¼¼Æ÷ÀÇ Áõ½ÄÀº º¸±â Èûµé´Ù.
  
  ¸¸¼º¸²ÇÁ¼º ¹éÇ÷º´Àº ¼­¾ç¿¡¼­´Â ºñ±³Àû ¹éÇ÷º´ Áß¿¡¼­ ÈçÇÑ ÇüÀÌÁö¸¸ µ¿¾ç±Ç¿¡¼­´Â ¾ÆÁÖ µå¹® ¹éÇ÷º´ÀÇ ÇüÅÂÀÌ´Ù. ´ë°³ 60¼¼ ÀÌ»óÀÇ °í·ÉÃþ¿¡¼­ ¸¹ÀÌ »ý±â°í 30¼¼ ÀÌÇÏ¿¡¼­´Â °ÅÀǠã¾Æº¼ ¼ö°¡ ¾ø´Ù. Ç÷¾×°Ë»ç»ó¿¡¼­ ¸²ÇÁ±¸ÀÇ ¸¹Àº Áõ°¡¸¦ º¼ ¼ö°¡ ÀÖ°í, ´ë½Å¿¡ ´Ù¸¥ Ç÷¾×¼¼Æ÷µéÀº °¨¼Ò¸¦ ³ªÅ¸³½´Ù. ¹éÇ÷º´ Áß ¿¹Èİ¡ ÁÁÀº ÆíÀ̸破밳 Ä¡·á´Â Ç×¾ÏÁ¦¸¦ ÀÌ¿ëÇÑ È­Çпä¹ýÀ» ¸¹ÀÌ »ç¿ëÇϸç, Æò±Õ »ýÁ¸±â°£Àº 4~5³âÀÌ´Ù.
¿µ¹® chronic obstructive pulmonary disease ÇÑ±Û ¸¸¼ºÆó¼âÆóº´
¼³¸í   
  ¸¸¼ºÀûÀ¸·Î ±âµµÀÇ Æó¼â¸¦ °¡Á®¿À´Â º´À» À̸£´Â ¸». ´ë°³ ¸¸¼º±â°üÁö¿°, ±â°üÁö Ãµ½Ä, Æó±âÁ¾ÀÇ 3°¡Áö º´À» ¸»ÇÑ´Ù.
  
  ¸¸¼º±â°üÁö¿°À̶õ ±â°üÁöÀÇ ¸¸¼º¿°ÁõÀ» ¸»ÇÑ´Ù. ±â°üÁöÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼­ ±â°üÁöÀÇ Á¡¸·¿¡ ºÎÁ¾ÀÌ »ý±â°í À̷ΠÀÎÇØ¼­ ±â°üÁöÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼­ ±âµµÀÇ Æó¼â¸¦ °¡Á®¿Â´Ù. ´ë°³ Èí¿¬°ú ¹ÐÁ¢ÇÑ ¿¬°üÀ» °¡Áö¸ç, È£Èí°ï¶õ, ±âħ, ±×¸®°í °¡·¡(´ë°³ »öÀ̠Ǫ¸£°í Á¡µµ°¡ ³ôÀº °¡·¡)°¡ Áõ»óÀ¸·Î ³ªÅ¸³­´Ù.
  
  Æó±âÁ¾Àº ±â°üÁöÀÇ º®À» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ ±â°üÁö°¡ Á¦ ¸ð¾çÀ» °®ÃßÁö ¸øÇÏ°í ¹«³ÊÁö°Ô µÇ¾î ±âµµÀÇ Æó¼â°¡ ÀϾ´Â º´ÀÌ´Ù. Áï ±â°üÁö°¡ °ü ¸ð¾çÀ¸·Î ÆØÆØÇϰԠÆìÁö´Â °ÍÀ» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ °ü¸ð¾çÀ¸·Î ÆìÁöÁö ¸øÇØ °á±¹Àº ÆóÆ÷³»¿¡ °ø±â°¡ Â÷°í ÆóÆ÷º®ÀÌ ÆÄ¿­µÇ°í ±â°üÁö°¡ Á¼¾ÆÁö°Ô µÇ´Â º´À» ¸»ÇÑ´Ù.
  
  ±â°üÁöõ½ÄÀ̶õ ¿©·¯ °¡Áö Àڱؿ¡ ´ëÇØ¼­ ±â°üÁö°¡ °ú¹ÎÇÑ ¹ÝÀÀÀ» º¸¿©¼­ »ý±â´Â ±â°üÁöÀÇ °¡¿ªÀûÀΠÆó¼â¸¦ ÀǹÌÇÑ´Ù. Áï Á¤»óÀο¡°Ô¼­´Â ±â°üÁöÀÇ Æó¼â¸¦ º¸ÀÌÁö ¾Ê´Â Àڱؿ¡ ´ëÇØ¼­ ±â°üÁöÀÇ Æó¼â°¡ »ý±â°í ±× ÀÚ±ØÀÌ ¾øÀ» °æ¿ì¿¡´Â ±â°üÁöÀÇ Æó¼â°¡ ¾ø¾îÁö´Â º´À» ¸»ÇÑ´Ù. 
¿µ¹® chronic active hepatitis ÇÑ±Û ¸¸¼ºÈ°µ¿°£¿°
¼³¸í   
  BÇü °£¿°À̳ª ºñAÇü£­ºñBÇü °£¿°ÀÇ ¼Ó¹ßÁõÀ¸·Î ³ªÅ¸³ª´Â °£ÀÇ ¸¸¼º¿°ÁõÀÌ´Ù. °°Àº ÇüÅÂÀÇ º´ÀÌ ¼±Ãµ¼º ¶Ç´Â ÈÄõ°¨¸¶±Û·ÎºÒ¸°°áÇÌÁõÀ̳ª ¾î¶² Á¾·ùÀÇ ¾à¹° Åõ¿©¿¡ ¼ö¹ÝÇØ¼­ ³ªÅ¸³¯ ¼öµµ ÀÖ´Ù. Æ¯Â¡ÀûÀ¸·Î ¹®¸ÆºÎ¿¡ ÇüÁú¼¼Æ÷¿Í Å«Æ÷½Ä¼¼Æ÷ÀǠħÀ±, Á¶°¢±«»ç(°£¼Ò¿± ÁÖº¯ºÎ °£¼¼Æ÷ÀÇ ÆÄ±«) ¹× ¼¶À¯Áõ µîÀÇ Á¶Á÷¼Ò°ßÀ» ³ªÅ¸³½´Ù. º´ÀÇ °æ°ú´Â ¸Å¿ì ´Ù¾çÇϸç Àå±â°£ÀÇ ¹«Áõ»ó±â¸¦ º¸ÀÏ ¼öµµ ÀÖ°í ±× »çÀÌ »çÀÌ¿¡ È²´Þ, Àü½Å¼è¾à, ½Ä¿åºÎÁø ¹× ¹ß¿­ µîÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖÀ¸¸ç, ¶Ç ¹«¿ù°æÁõ, °üÀý¿°, ÇǺιßÁø, Ç÷°ü¿°, °©»ó»ù¿°, ÄáÆÏ»ç±¸Ã¼¿°, ±Ë¾ç¼º´ëÀå¿°, ½¦±×·»ÁõÈıº µî °£ ÀÌ¿ÜÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼öµµ ÀÖ°í, °£°æÈ­Áõ°ú °£±â´É»ó½Ç·Î ÁøÇàµÇ´Â ¼öµµ ÀÖ´Ù. ÀÚ°¡¸é¿ª¸ÞÄ¿´ÏÁòÀÌ °ü¿©µÇ´Â °ÍÀ¸·Î ÃßÃøµÇ°í ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic glomerulonephritis
    ¸¸¼ºÅ丮ÄáÆÏ¿°, ¸¸¼º»ç±¸Ã¼½Å¿°
  • crescentic glomerulonephritis
    Ãʽ´ÞÅ丮ÄáÆÏ¿°, Ãʽ´޻籸ü½Å¿°
  • diffuse proliferative glomerulonephritis
    ±¤¹üÀ§Áõ½ÄÅ丮ÄáÆÏ¿°, ±¤¹üÀ§Áõ½Ä»ç±¸Ã¼½Å¿°
  • exudative proliferative glomerulonephritis
    »ïÃâÁõ½ÄÅ丮ÄáÆÏ¿°, »ïÃâÁõ½Ä»ç±¸Ã¼½Å¿°
  • focal embolic glomerulonephritis
    ÃÊÁ¡»öÀüÅ丮ÄáÆÏ¿°, ÃÊÁ¡»öÀü»ç±¸Ã¼½Å¿°
  • focal glomerulonephritis
    ÃÊÁ¡Å丮ÄáÆÏ¿°, ÃÊÁ¡»ç±¸Ã¼½Å¿°
  • focal proliferative glomerulonephritis
    ÃÊÁ¡Áõ½ÄÅ丮ÄáÆÏ¿°, ÃÊÁ¡Áõ½Ä»ç±¸Ã¼½Å¿°
  • focal segmental glomerulonephritis
    ÃÊÁ¡ºÐÀýÅ丮ÄáÆÏ¿°, ÃÊÁ¡ºÐÀý»ç±¸Ã¼½Å¿°
  • glomerulonephritis
    Å丮ÄáÆÏ¿°, »ç±¸Ã¼½Å¿°
  • idiopathic crescentic glomerulonephritis
    Ư¹ßÃʽ´ÞÅ丮ÄáÆÏ¿°, Ư¹ßÃʽ´޻籸ü½Å¿°
  • intercapillary glomerulonephritis
    ¸ð¼¼°ü»çÀÌÅ丮ÄáÆÏ¿°, ¸ð¼¼°ü°£»ç±¸Ã¼½Å¿°
  • membranoproliferative glomerulonephritis
    ¸·Áõ½ÄÅ丮ÄáÆÏ¿°, ¸·Áõ½Ä»ç±¸Ã¼½Å¿°
  • membranous glomerulonephritis
    ¸·Å丮ÄáÆÏ¿°, ¸·»ç±¸Ã¼½Å¿°
  • mesangial proliferative glomerulonephritis
    Ç÷°ü»çÀÌÁúÁõ½ÄÅ丮ÄáÆÏ¿°, Ç÷°ü°£¼¼Æ÷Áõ½Ä»ç±¸Ã¼½Å¿°
  • mesangiocapillary glomerulonephritis
    Ç÷°ü»çÀÌÁú¸ð¼¼°üÅ丮ÄáÆÏ¿°, »ç±¸Ã¼Ç÷°ü°£Áú¸ð¼¼°ü»ç±¸Ã¼½Å¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anemia of chronic disease
    ¸¸¼ºº´ºóÇ÷
  • chronic
    ¸¸¼º-
  • chronic renal failure
    ¸¸¼ºÄáÆÏ±â´É»ó½Ç, ¸¸¼º½ÅºÎÀü(Áõ)
  • chronic atrophic gastritis
    ¸¸¼ºÀ§ÃàÀ§¿°
  • chronic relapsing pancreatitis
    ¸¸¼ºÀç¹ßÀÌÀÚ¿°, ¸¸¼ºÀç¹ßÃéÀå¿°
  • glomerulonephritis
    Å丮ÄáÆÏ¿°, »ç±¸Ã¼½Å¿°
  • crescentic glomerulonephritis
    Ãʽ´ÞÅ丮ÄáÆÏ¿°, Ãʽ´޻籸ü½Å¿°
  • idiopathic crescentic glomerulonephritis
    Ư¹ßÃʽ´ÞÅ丮ÄáÆÏ¿°, Ư¹ßÃʽ´޻籸ü½Å¿°
  • membranoproliferative glomerulonephritis
    ¸·Áõ½ÄÅ丮ÄáÆÏ¿°, ¸·Áõ½Ä»ç±¸Ã¼½Å¿°
  • membranous glomerulonephritis
    ¸·Å丮ÄáÆÏ¿°, ¸·»ç±¸Ã¼½Å¿°
  • poststreptococcal glomerulonephritis
    »ç½½¾Ë±Õ°¨¿°ÈÄÅ丮ÄáÆÏ¿°, ¿¬¼â±¸±Õ°¨¿°ÈĻ籸ü½Å¿°
  • rapidly progressive glomerulonephritis
    ±Þ¼ÓÁøÇàÅ丮ÄáÆÏ¿°, ±Þ¼ÓÁøÇà»ç±¸Ã¼½Å¿°
  • mesangial proliferative glomerulonephritis
    Ç÷°ü»çÀÌÁúÁõ½ÄÅ丮ÄáÆÏ¿°, Ç÷°ü°£¼¼Æ÷Áõ½Ä»ç±¸Ã¼½Å¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic
    ¸¸¼º-
  • chronic active photosensitive dermatitis
    ¸¸¼ºÈ°¼º±¤¼±°ú¹ÎÇǺο°
  • chronic exposure
    ¸¸¼ºÇÇÆø, ¸¸¼º³ëÃâ
  • chronic active hepatitis
    ¸¸¼ºÈ°µ¿°£¿°
  • chronic fatigue syndrome
    ¸¸¼ºÇÇ·ÎÁõÈıº
  • chronic granulomatous disease
    ¸¸¼ºÀ°¾ÆÁ¾º´
  • chronic hypertrophic rhinitis
    ¸¸¼ººñÈÄÄÚ¿°, ¸¸¼ººñÈĺñ¿°
  • chronic myeloproliferative disorder
    ¸¸¼º°ñ¼öÁõ½ÄÁúȯ
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ, ¸¸¼ºÆó¼âÆóº´
  • chronic pain syndrome
    ¸¸¼ºÅëÁõÁõÈıº
  • chronic persistent hepatitis
    ¸¸¼ºÁö¼Ó°£¿°
  • chronic progressive disciform granulomatosis
    ¸¸¼ºÁøÇà¿ø¹ÝÀ°¾ÆÁ¾Áõ
  • chronic relapsing pancreatitis
    ¸¸¼ºÀç¹ßÀÌÀÚ¿°
  • chronic vasomotor instability
    ¸¸¼ºÇ÷°ü¿îµ¿ºÒ¾ÈÁ¤
  • crescentric glomerulonephritis
    Ãʽ´ÞÅ丮ÄáÆÏ¿°, Ãʽ´޻籸ü½Å¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • COPD=> chronic obstructive pulmonary disease
    ¸¸¼ºÆó»ö(¼â)¼º ÆóÁúȯ(Ø·àõøÍßáàõøËòðü´)
  • Chronic fatigue syndrome
    ¸¸¼ºÇÇ·Î ÁõÈıº
  • Hailey-Hailey disease = familial benign chronic pemphigus
    ÇìÀϸ®-ÇìÀϸ®º´
  • hepatitis,chronic active
    ¸¸¼ºÈ°µ¿¼º(Ø·àõüÀÔÑàõ)
  • hepatitis,chronic persistent
    ¸¸¼ºÁö¼Ó¼º(Ø·àõò¥áÙàõ)
  • pharyngitis, chronic
    ¸¸¼ºÀεο°
  • pharyngitis, chronic hypertrophic
    ¸¸¼ººñÈÄ(¼º) Àεο°
  • pharyngitis, chronic lateral
    ¸¸¼º¿ÜÃø(¼º) Àεο°
  • acute glomerulonephritis
    ±Þ¼º»ç±¸Ã¼½Å¿°
  • acute glomerulonephritis
    ±Þ¼º »ç±¸Ã¼½Å¿°(¡­ÞêϹô÷ãìæú).
  • glomerulonephritis
    »ç±¸Ã¼¼º ½Å¿°
  • glomerulonephritis
    »ç±¸Ã¼½Å¿°.
  • glomerulonephritis
    »ç±¸Ã¼½Å¿°.(ÞêϹô÷ãìæú)
  • glomerulonephritis
    »ç±¸Ã¼½Å¿°
  • glomerulonephritis,diffuse proliferative
    ¹Ì¸¸¼º Áõ½Ä¼º(ڵؼàõ ñòãÖàõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute glomerulonephritis
    ±Þ¼º »ç±¸Ã¼½Å¿°(¡­ÞêϹô÷ãìæú).
  • acute glomerulonephritis
    ±Þ¼º»ç±¸Ã¼½Å¿°
  • crescentric glomerulonephritis
  • focal glomerulonephritis
    ÃÊÁ¡¼º »ç±¸Ã¼ ½Å¿°.
  • focal glomerulonephritis
    ÃÊÁ¡¼º »ç±¸Ã¼½Å¿°(¡­ÞêϹô÷ ãìæú)
  • focal segmental glomerulonephritis
    ÃÊÁ¡¼º ºÐÀý(¼º) »ç±¸Ã¼½Å¿°
  • glomerulonephritis
    »ç±¸Ã¼½Å¿°
  • glomerulonephritis
    »ç±¸Ã¼½Å¿°.
  • glomerulonephritis
    »ç±¸Ã¼½Å¿°.(ÞêϹô÷ãìæú)
  • glomerulonephritis
    »ç±¸Ã¼¼º ½Å¿°
  • glomerulonephritis,diffuse proliferative
    ¹Ì¸¸¼º Áõ½Ä¼º(ڵؼàõ ñòãÖàõ)
  • glomerulonephritis,focal embolic
    ÃÊÁ¡¼º »öÀü¼º
  • glomerulonephritis,focal proliferative
    ÃÊÁ¡¼º Áõ½Ä¼º
  • glomerulonephritis,membranoproliferative
    ¸·Áõ½Ä¼º
  • glomerulonephritis,membranous
    ¸·¼º
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic malaria
    ¸¸¼º¸»¶ó¸®¾Æ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic toxicity test
    ¸¸¼º µ¶¼º½ÃÇè(Ø·àõÔ¸àõãËúÐ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic
    ¸¸¼ºÀÇ
  • focal glomerulonephritis
    ÃÊÁ¡¼º»ç±¸Ã¼½Å¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MCGN mesangiocapillary glomerulonephritis; minimal change glomerulonephritis; mixed cryoglobulinemia with...
HVUS hypocomplementemic vasculitis urticaria syndrome
CP candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta...
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
CPH Certificate in Public Health; chronic paroxysmal hemicrania; chronic persistent hepatitis; chronic p...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HUVS Hypocomplementemic urticarial vasculitis syndrome
CGN Chronic glomerulonephritis
APSGN Acute Poststreptococcal Glomerulonephritis
AGN Acute glomerulonephritis
AGN Acute poststreptococcal glomerulonephritis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute glomerulonephritis
    ±Þ¼º »ç±¸Ã¼ ½Å¿°
    ÇüÅÂÇÐÀûÀ¸·Î´Â ±Þ¼º ¹Ì¸¸¼º Áõ½Ä¼º »ç±¸Ã¼½Å¿°À» ÀÏÀ¸Å°°í ÀÓ»óÀûÀ¸·Î´Â Ç÷´¢, °íÁú¼ÒÇ÷Áõ, ÇÌ´¢, °íÇ÷¾Ð µîÀÇ ±Þ¼º ½Å¿° ÁõÈıºÀ» ÁÖ¼Ò·Î ÇÏ´Â ½Å¿°À¸·Î ´Ü¹é´¢ ¹× ºÎÁ¾ µîµµ µ¿¹ÝµÉ ¼ö ÀÖÀ¸³ª ½ÅÁõÈıºº¸´Ù Á¤µµ°¡ ½ÉÇÏÁö ¾ÊÀº °æ¿ì°¡ ´ëºÎºÐÀÌ´Ù.
  • acute poststreptococcal glomerulonephritis
    ±Þ¼º ¿¬¼â»ó ±¸±Õ¼º »ç±¸Ã¼ ½Å¿°
    A±º ¿¬¼â»ó ±¸±Õ °¨¿°ÀÌ ¿øÀÎÀÌ µÇ¾î ¹ß»ýÇÏ´Â ±Þ¼º ½Å¿°ÀÌ´Ù. ¿¬¼â»ó ±¸±Õ¿¡ ÀÇÇÑ Æíµµ¿° µîÀÌ Ä¡À¯µÇ¾î¼­ 1-2ÁÖ ÈÄ¿¡ µ¹¿¬ ºÎÁ¾, ÇÌ´¢, °íÇ÷¾Ð µîÀ» µ¿¹ÝÇØ¼­ ¹ßº´ÇÑ´Ù. ¼Ò¾Æ¿¡ ¸¹ÀÌ ¹ßº´Çϳª ¼ºÀο¡°Ôµµ µå¹°Áö´Â ¾ÊÀ¸¸ç, ¾à 90%´Â 1-2°³¿ù ÈÄ¿¡ ¿ÏÀüÈ÷ Ä¡À¯µÈ´Ù. Ç÷û ASLO °ªÀÇ »ó½Â°ú Ç÷û º¸Ã¼°¡ÀÇ °¨¼Ò°¡ Áø´Ü¿¡ µµ¿òÀÌ µÈ´Ù. ÀÌ Áõ»óÀº ¿¬¼â»ó ±¸±ÕÀÇ Ç׿ø°ú ±× Ç×ü¿¡ ÀÇÇÑ ¸é¿ª º¹ÇÕü ½Å¿°ÀÌ´Ù. ƯÈ÷ ¼Ò¾Æ¿¡¼­´Â ±Þ¼º±â¿¡ °íÇ÷¾Ð¿¡ ÀÇÇÑ ½ÉºÎÀü, °æ·ÃÀ» ÀÏÀ¸Å°±â ½±±â ¶§¹®¿¡ ÁÖÀǸ¦ ¿äÇÑ´Ù.
  • focal glomerulonephritis
    ÃÊÁ¡¼º »ç±¸Ã¼ ½Å¿°
  • focal proliferative glomerulonephritis
    ÃÊÁ¡¼º Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°
  • membranoproliferative glomerulonephritis
    ¸· Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°
    ¸¸¼º »ç±¸Ã¼ ½Å¿°ÀÇ ÇÑ À¯ÇüÀ¸·Î, Ç÷°ü°£ ¼¼Æ÷ Áõ½Ä°ú »ç±¸Ã¼ ¸ð¼¼Ç÷°üÀÇ ºÒ±ÔÄ¢ÀûÀÎ ºñÈĸ¦ Ư¡À¸·Î ÇÑ´Ù. ÀÌ¿¡´Â µÎ °³ÀÇ ¾ÆÇüÀÌ ÀÖ´Ù. Á¦ 1ÇüÀº ³»ÇǼ¼·ÎÇÏ ÀüÀÚ ¹Ðµµ Ä§Âø°ú ÀüÇüÀûÀÎ º¸Ã¼ °æ·Î Ȱ¼ºÈ­°¡ ³ªÅ¸³ª¸ç, Á¦2ÇüÀº ½ÉÇÑ ÀüÀÚ ¹Ðµµ Ä§ÂøÀÌ »ç±¸Ã¼ ±âÀú¸·¿¡ »ý±â¸ç C3 ½Å¿° ÀÎÀÚ¸¦ Æ÷ÇÔÇÑ ±³´ëÀû º¸Ã¼ °æ·Î Ȱ¼ºÈ­°¡ ÀϾ´Ù. À̴ û¼Ò³âÀ̳ª ÀþÀº ¼ºÀÎÃþ¿¡°Ô ¹ßº´Çϸç, ºÒ±ÔÄ¢ÀûÀΠȸº¹À» µ¿¹ÝÇϸ鼭 õõÈ÷ ÁøÇàÇÏ¿© ±Ã±ØÀûÀ¸·Î´Â ½ÅºÎÀü¿¡ ºüÁø´Ù.
  • chronic abscess
    ¸¸¼º ³ó¾ç
  • chronic acid
    Å©·Ò»ê
  • chronic acral dermatitis
    ¸¸¼º ¸»´Ü ÇǺο°
  • chronic actinic damage
    ¸¸¼º ±¤È­Çм± ¼Õ»ó
  • chronic active hepatitis
    ¸¸¼º Ȱµ¿¼º °£¿°
  • chronic alveolar abscess
    ¸¸¼º Ä¡Á¶ ³ó¾ç
    Ä¡±Ù´Ü Ä¡Á¶°ñÀÌ Àå±â°£ µ¿¾È ³·Àº Á¤µµ·Î °¨¿°µÈ °Í.
  • chronic ambulatory peritoneal dialysis
    Áö¼Ó¼º ¿Ü·¡ º¹¸· Åõ¼®
  • chronic atrophic candidiasis
    ¸¸¼º À§Ã༺ ĵµð´ÙÁõ
    º¸Ã¶¹°°ú Á¢Ã˵Ǵ ºÎÀ§ÀÇ Á¡¸·ÀÌ ¸Å²öÇϰí À§ÃàÀÌ µÇ¸ç ¸íÈ®ÇÏ°Ô Àû»öÀ¸·Î µÇ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. ÀÌÈÄ¿¡ À̰ÍÀº ±Ù¿øÀÌ ´Ù¸¥ º¸Ã¶¹° ±¸³»¿°°ú º¸Ã¶¹°¿¡ ´ëÇÑ Á¢Ã˼º ¾Ë·¹¸£±â ¹ÝÀÀ°ú ±¸ºÐÇÏ¿©¾ß ÇÏ´Â À¯µÎ¼º ¼Ò°ßÀ» À¯¹ßÇÒ °¡´É¼ºÀÌ ÀÖ´Ù.
  • chronic atrophic laryngitis
    ¸¸¼º À§Ãà Èĵο°, ¸¸¼º À§Ã༺ Èĵο°
  • chronic bactrial prostatitis
    ¸¸¼º ¼¼±Õ¼º Àü¸³¼±¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
hypocomplementemic glomerulonephritis <pathology> A kidney disorder which results in kidney dysfunction. Inflammation of the glomeruli result from an abnormal immune response and the deposition of antibodies within the kidney (glomerulus) ultrastructure.
Membranoproliferative glomerulonephritis has been divided into two different types in the basis of where the antibodies are deposited in the glomerulus. MPGN type I, the more common type, deposits antibodies in the subendothelial layer of the basement membrane, whereas type II deposits antibodies in the bottom layer of the basement membrane.
Symptoms include cloudy urine (pyuria), decreased urine output, swelling and hypertension. This disorder often results in end-stage renal disease.
Acronym: MPGN
(26 Mar 1998)
hypocomplementemic vasculitis Cutaneous lesions resembling urticaria but lasting more than 24 hours, with biopsy findings of leukocytoclastic vasculitis and variable systemic changes, usually with hypocomplementemia.
Synonym: hypocomplementemic vasculitis.
(05 Mar 2000)
chronic glomerulonephritis Glomerulonephritis that presents with persisting proteinuria, chronic renal failure, and hypertension, of insidious onset or as a late sequel of acute glomerulonephritis; the kidneys are symmetrically contracted and granular, with scarring and loss of glomeruli and the presence of tubular atrophy and interstitial fibrosis.
Synonym: chronic nephritis.
(05 Mar 2000)
acute crescentic glomerulonephritis <nephrology> A relatively uncommon (affecting 1 out of 10,000 people) form of acute glomerulonephritis that results in damage within the glomerulus of the kidney. There is rapid loss of kidney function with the formation of crescents on microscopic analysis (kidney biopsy). This disorder may result in acute glomerulonephritis or nephrotic syndrome, but ultimately results in renal failure and end-stage renal disease.
Symptoms include smoky coloured urine (pyuria), decreased urine output, swelling and hypertension. Any conditions which can cause a vasculitis increase the risk of this disorder. Some examples include lupus, Goodpasture's syndrome, Henoch-Schonlein purpura, IgA nephropathy, membranoproliferative glomerulonephritis, anti-glomerular basement membrane antibody disease, history for malignant tumours and exposure to hydrocarbon solvents.
(27 Sep 1997)
acute glomerulonephritis <nephrology> A disease of the kidneys that results in inflammation of the glomerulus (the portion of the kidney that filters the blood).
Conditions which may cause glomerulonephritis include post-streptococcal disease (strep throat), lupus, syphilis, bacterial endocarditis, membranoproliferative glomerulonephritis, sepsis, vasculitis, Goodpasture's syndrome, typhoid fever, Henoch-Schonlein purpura, hepatitis or a viral infection (for example mumps, measles, mononucleosis).
(27 Sep 1997)
acute haemorrhagic glomerulonephritis <nephrology> A disease of the kidneys that results in inflammation of the glomerulus (the portion of the kidney that filters the blood).
Conditions which may cause glomerulonephritis include post-streptococcal disease (strep throat), lupus, syphilis, bacterial endocarditis, membranoproliferative glomerulonephritis, sepsis, vasculitis, Goodpasture's syndrome, typhoid fever, Henoch-Schonlein purpura, hepatitis or a viral infection (for example mumps, measles, mononucleosis).
(27 Sep 1997)
acute post-streptococcal glomerulonephritis <nephrology> A disease of the kidneys that results in inflammation of the glomerulus (the portion of the kidney that filters the blood).
Conditions which may cause glomerulonephritis include post-streptococcal disease (strep throat), lupus, syphilis, bacterial endocarditis, membranoproliferative glomerulonephritis, sepsis, vasculitis, Goodpasture's syndrome, typhoid fever, Henoch-Schonlein purpura, hepatitis or a viral infection (for example mumps, measles, mononucleosis).
(27 Sep 1997)
anti-basement membrane glomerulonephritis Glomerulonephritis resulting from anti-basement membrane antibodies, characterised by smooth linear deposits of IgG and C3 along glomerular capillary walls; includes rapidly progressive glomerulonephritis and glomerulonephritis in Goodpasture's syndrome.
(05 Mar 2000)
Berger's focal glomerulonephritis Glomerulonephritis affecting a small proportion of renal glomeruli which commonly presents with haematuria and may be associated with acute upper respiratory infection in young males, not usually due to streptococci; associated with IgA deposits in the glomerular mesangium and may also be associated with systemic disease, as in Henoch-Schonlein purpura.
Synonym: Berger's disease, Berger's focal glomerulonephritis, focal nephritis, IgA nephropathy.
(05 Mar 2000)
rapidly progressive glomerulonephritis <nephrology> A relatively uncommon (affecting 1 out of 10,000 people) form of acute glomerulonephritis that results in damage within the glomerulus of the kidney. There is rapid loss of kidney function with the formation of crescents on microscopic analysis (kidney biopsy). This disorder may result in acute glomerulonephritis or nephrotic syndrome, but ultimately results in renal failure and end-stage renal disease.
Symptoms include smoky coloured urine (pyuria), decreased urine output, swelling and hypertension. Any conditions which can cause a vasculitis increase the risk of this disorder. Some examples include lupus, Goodpasture's syndrome, Henoch-Schonlein purpura, IgA nephropathy, membranoproliferative glomerulonephritis, anti-glomerular basement membrane antibody disease, history for malignant tumours and exposure to hydrocarbon solvents.
(27 Sep 1997)
glomerulonephritis <nephrology> A variety of nephritis characterised by inflammation of the capillary loops in the glomeruli of the kidney. It occurs in acute, subacute and chronic forms and may be secondary to haemolytic streptococcal infection. Evidence also supports possible immune or autoimmune mechanisms.
(18 Nov 1997)
glomerulonephritis, IgA Chronic form of glomerulonephritis characterised by recurring haematuria with only slight proteinuria and by deposits of IgA immunoglobulin in the mesangial areas of the renal glomeruli. It usually occurs in young males.
(12 Dec 1998)
glomerulonephritis, membranoproliferative Chronic glomerulonephritis characterised histologically by proliferation of mesangial cells, increase in the mesangial matrix, and a thickening of the glomerular capillary walls. The wall thickening is sometimes said to be a result of the interposition of mesangial cytoplasm or matrix between the basement membrane and the endothelium of the capillary wall. It is often divided into types I and II, and sometimes III. Pathogenesis is not well understood, but some types are thought to involve the immune system, with the complement system, in particular, being implicated.
(12 Dec 1998)
glomerulonephritis, membranous A disease of the glomerulus manifested clinically by proteinuria, and sometimes by other features of the nephrotic syndrome. It is histologically characterised by deposits in the glomerular capillary wall between the epithelial cell and the basement membrane and a thickening of the membrane. Also characteristic are outward projections of the membrane between the epithelial deposits in the form of "spikes". There is some agreement that the deposits are antigen-antibody complexes.
(12 Dec 1998)
membranoproliferative glomerulonephritis <pathology> A kidney disorder which results in kidney dysfunction. Inflammation of the glomeruli result from an abnormal immune response and the deposition of antibodies within the kidney (glomerulus) ultrastructure.
Membranoproliferative glomerulonephritis has been divided into two different types in the basis of where the antibodies are deposited in the glomerulus. MPGN type I, the more common type, deposits antibodies in the subendothelial layer of the basement membrane, whereas type II deposits antibodies in the bottom layer of the basement membrane.
Symptoms include cloudy urine (pyuria), decreased urine output, swelling and hypertension. This disorder often results in end-stage renal disease.
Acronym: MPGN
(26 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic
    ¸¸¼ºÀûÀÎ
  • chronic
    Àå±â°£¿¡ °ÉÄ£;¿À·¡ °Ô¼ÓÇÏ´Â;¸¸¼ºÀûÀÎ;¹ö¸©ÀÌ µÈ;»ó½ÀÀûÀÎ;(º´ÀÌ)¸¸¼ºÀÇ;°íÁúÀÇ;½ÈÀº;½ÉÇÑ;¸¸¼ºº´ ȯÀÚ;Áöº´À» °¡Áø »ç¶÷;ically ¸¸¼ºÀûÀ¸·Î;ÁúÁú ½Ã°£À» ²ø¾î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á